Design and exploratory data analysis of a second generation of dendrimer prodrugs potentially antichagasic and leishmanicide

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular diversity

• Publication date

  2013-08-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11030-013-9467-5PMID 23990201
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chagas' Disease.

  2015cited by this paper
• Tankyrase 2 in complex with 4'-nitro flavone

  2013cited by this paper
• Association of nicotinic acid with a poly(amidoamine) dendrimer studied by molecular dynamics simulations.

  2013cited by this paper
• Study of interaction energies between the PAMAM dendrimer and nonsteroidal anti-inflammatory drug using a distributed computational strategy and experimental analysis by ESI-MS/MS.

  2012cited by this paper
• Antitumor activity and molecular dynamics simulations of paclitaxel-laden triazine dendrimers.

  2012cited by this paper
• Tankyrase 2 in complex with flavone

  2012cited by this paper
• PAMAM dendrimer-drug interactions: effect of pH on the binding and release pattern.

  2012cited by this paper
• Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

  2012cited by this paper
• Biomedical applications of dendrimers: a tutorial.

  2011cited by this paper
• Regulation and structure of YahD, a copper-inducible α/β serine hydrolase of Lactococcus lactis IL1403.

  2011cited by this paper
• Antiprotozoal compounds: state of the art and new developments.

  2011cited by this paper
• Infectious diseases. Drug developers finally take aim at a neglected disease.

  2011cited by this paper
• Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications.

  2010cited by this paper
• Chagas disease: a new worldwide challenge

  2010cited by this paper
• Chagas disease.

  2010cited by this paper
• Hydroxymethylnitrofurazone Is Active in a Murine Model of Chagas' Disease

  2010cited by this paper
• Leishmaniasis, an emerging infection in travelers.

  2010cited by this paper
• Programmes, partnerships, and governance for elimination and control of neglected tropical diseases.

  2010cited by this paper
• New antileishmanial candidates and lead compounds.

  2010cited by this paper
• Bringing neglected tropical diseases into the spotlight.

  2010cited by this paper
• Rational Approaches for Drug Designing Against Leishmaniasis

  2010cited by this paper
• Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.

  2010cited by this paper
• Bioinspired application of dendrimers: From bio-mimicry to biomedical applications

  2009cited by this paper
• Dendrimers as versatile platform in drug delivery applications.

  2009cited by this paper
• Neglected tropical diseases in Brazil.

  2009cited by this paper
• Prodrugs for the Treatment of Neglected Diseases

  2008cited by this paper
• Crystal structure of human beta-hydroxyisobutyryl-CoA hydrolase in complex with quercetin

  2008cited by this paper
• Dendrimers as drug carriers: applications in different routes of drug administration.

  2008cited by this paper
• Critical role of Arg/Lys343 in the species-dependent recognition of phosphatidylinositol by pulmonary surfactant protein D.

  2007cited by this paper
• Control of neglected tropical diseases.

  2007cited by this paper
• In vitro evaluation of dendrimer prodrugs for oral drug delivery.

  2007cited by this paper
• Control of neglected tropical diseases.

  2007cited by this paper
• Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.

  2007cited by this paper
• Synthesis, characterization and stability of dendrimer prodrugs.

  2006cited by this paper
• Antitrypanosomal and Antileishmanial Activities of Flavonoids and Their Analogues: In Vitro, In Vivo, Structure-Activity Relationship, and Quantitative Structure-Activity Relationship Studies

  2006cited by this paper
• Advances in prodrug design.

  2005cited by this paper
• Dendrimer-drug interactions.

  2005cited by this paper
• 5‐Nitro‐2‐furaldehyde N‐(hydroxy­methyl)semicarbazone

  2005cited by this paper
• Dendrimers in biomedical applications--reflections on the field.

  2005cited by this paper
• Transport of dendrimer nanocarriers through epithelial cells via the transcellular route.

  2004cited by this paper
• The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability.

  2004cited by this paper
• Natural products as antiparasitic drugs

  2003cited by this paper
• Synthesis and in vitro evaluation of potential antichagasic hydroxymethylnitrofurazone (NFOH-121): a new nitrofurazone prodrug.

  2003cited by this paper
• Multivariate QSAR

  2002cited by this paper
• Diminuicao da atividade mutagenica do pro-farmaco NFOH-121 em relacao ao nitrofural (nitrofurazona)

  2001cited by this paper
• The increase in risk factors for leishmaniasis worldwide.

  2001cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Designing dendrimers for drug delivery.

  1999cited by this paper
• O processo de latenciação no planejamento de fármacos

  1999cited by this paper
• Quimiometria I: calibração multivariada, um tutorial

  1999cited by this paper
• Prediction of Ligand-Receptor Binding Thermodynamics by Free Energy Force Field (FEFF) 3D-QSAR Analysis: Application to a Set of Peptidometic Renin Inhibitors

  1997cited by this paper
• Prediction of Ligand‐Receptor Binding Thermodynamics by Free Energy Force Field (FEFF) 3D‐QSAR Analysis: Application to a Set of Peptidometic Renin Inhibitors.

  1997cited by this paper
• Atomic Physicochemical Parameters for Three‐Dimensional Structure‐Directed Quantitative Structure‐Activity Relationships I. Partition Coefficients as a Measure of Hydrophobicity

  1986cited by this paper
• A New Class of Polymers: Starburst-Dendritic Macromolecules

  1985cited by this paper
• Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

  1985cited by this paper
• Solvent-accessible surfaces of proteins and nucleic acids.

  1983cited by this paper
• Probe of beta-galactosidase structure with iodoacetate. Differential reactivity of thiol groups in wild-type and mutant forms of beta-galactosidase.

  1978cited by this paper
• Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms

  1977cited by this paper
• Conformational analysis—CI

  1974cited by this paper
• The Influence of Solvent on the Secondary Structures of Poly(L-alanine) and Poly(L-proline)

  1973cited by this paper

• How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease?

  2024cites this paper
• Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties

  2022cites this paper
• Opportunities and challenges for flavonoids as potential leads for the treatment of tuberculosis

  2020cites this paper
• Flavones as a Privileged Scaffold in Drug Discovery: Current Developments.

  2019cites this paper
• In vitro activity of steroidal dendrimers on Trypanosoma cruzi epimastigote form with PAMAM dendrons modified by "click" chemistry.

  2019cites this paper
• Innovative Solutions for the Control of Leishmaniases: Nanoscale Drug Delivery Systems.

  2019cites this paper
• Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue

  2019cites this paper
• Dendrimers in the context of nanomedicine.

  2019cites this paper
• Nanosize Dendrimers: Potential Use as Carriers and Antimicrobials

  2017cites this paper
• Dendrimer Prodrugs

  2016cites this paper
• Characterization and evaluation of amphotericin B loaded MDP conjugated poly(propylene imine) dendrimers.

  2015cites this paper
• Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis.

  2015cites this paper
• Drug design for neglected disease in Brazil.

  2015cites this paper